Home 2021 Medical Marijuana Update

Medical Marijuana Update

by Paul Ebeling

#medical #marijuana, cannabis

A New Jersey appeals court clears the way for dealing with pending medical marijuana license applications, and there was lots of action in the states this wk” — Paul Ebeling

New Jersey

New Jersey Medical Marijuana Licensing to Resume After Appellate Court Ruling. The state’s appellate court ruled last Thursday to uphold the denial of seven medical marijuana licenses, clearing the way for the state to begin dealing with nearly 150 license applications that have piled up while the case was being contested.

North Dakota

North Dakota House Approves Medical Marijuana Edibles. The House has approved a measure, House Bill 1391, that would allow medical marijuana patients to use edibles. The bill would limit edibles to 10 milligrams of THC and allow patients to possess edibles with up to 500 milligrams.

Oklahoma

Oklahoma House Approves Expanding Non-Resident Medical Marijuana Patient Licenses. The House voted last Thursday to approve House Bill 2022, which would extend the length of medical marijuana licenses granted to out-of-state residents. The bill would lengthen the licenses’ period of validity from 30 days to 2 yrs. The bill also would open up licenses to resident of all 50 states, not just those with existing medical marijuana. The bill must still be approved by the Senate.

South Dakota

South Dakota House Votes to Deny Telehealth for Medical Marijuana. The House voted 38-30 last Wednesday to defeat House Bill 1147, which would have allowed medical marijuana patients to use telehealth to consult with practitioners in order to obtain recommendations. One Republican opponent called the idea “premature,” while another called it “not ready for prime time.” South Dakota okayed medical marijuana with 69% of the vote in November.

South Dakota Medical Marijuana Supporters Float Compromise to Forestall GOP Effort to Delay Implementation. Supporters of the state’s voter-approved medical marijuana law are seeking to scale back Republican efforts to delay the implementation of the medical marijuana program. Lawmakers are considering House Bill 1100, which would form an interim committee to essentially rewrite the voter-approved law. The proposal moves back the deadline for implementing much of the measure to next January during the Y 2022 legislative session.

Virginia

Virginia General Assembly Approves Sales of Buds for Medical Marijuana Patients. A bill that would allow medical marijuana patients to buy flowers, House Bill 221, has passed the General Assembly. Currently, only highly processed oils, tinctures and edibles are allowed to be sold. The bill now goes to Governor Ralph Northam (D).

By Phillip Smith

Paul Ebeling, Editor

Permission to Reprint: This article is licensed under a modified Creative Commons Attribution license.

Looking for the easiest way to join the anti-drug war movement? You have found it!

Have a healthy weekend, Keep the Faith!

You may also like

logo-white

Your Trusted Source for Capital Markets & Related News

© 2024 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.